Viewing Study NCT02319135


Ignite Creation Date: 2025-12-24 @ 10:40 PM
Ignite Modification Date: 2026-01-02 @ 12:23 AM
Study NCT ID: NCT02319135
Status: COMPLETED
Last Update Posted: 2020-04-06
First Post: 2014-12-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Azacytidine (Vidaza®) Versus Fludarabine and Cytarabine (Fluga Scheme) in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Sponsor: PETHEMA Foundation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module